Sale!

Cleveland Clinic Cardiovascular Update 2025

Original price was: $599.99.Current price is: $99.99.

-83%
Customers Who Bought This Book Also Bought
The 4th Annual NYU Langone Critical Care Cardiology Symposium 2024 (Videos)
The 4th Annual NYU Langone Critical Care Cardiology Symposium 2024 (Videos) Original price was: $699.99.Current price is: $144.99.
Penn Medicine UPenn HFpEF Symposium 2025
Penn Medicine UPenn HFpEF Symposium 2025 Original price was: $599.99.Current price is: $99.99.
Mayo Clinic Interventional Cardiology Online Board Review 2024
Mayo Clinic Interventional Cardiology Online Board Review 2024 Original price was: $799.99.Current price is: $144.99.
Society of Cardiovascular Computed Tomography Board Review and Update of Cardiovascular CT Course 2025
Society of Cardiovascular Computed Tomography Board Review and Update of Cardiovascular CT Course 2025 Original price was: $799.99.Current price is: $149.99.
American Society of Echocardiography Echo Florida Online Library 2025
American Society of Echocardiography Echo Florida Online Library 2025 Original price was: $699.99.Current price is: $133.90.
Cedars Sinai Cardiac Imaging 2026: Elite CME Review
Cedars Sinai Cardiac Imaging 2026: Elite CME Review Original price was: $799.99.Current price is: $149.99.
Columbia 2024 Challenges in Hypertension – 12th Annual
Columbia 2024 Challenges in Hypertension – 12th Annual Original price was: $799.99.Current price is: $99.99.
26th Annual ASCeXAM Review Course 2025
26th Annual ASCeXAM Review Course 2025 Original price was: $799.99.Current price is: $133.99.
Total : $1,057.83

Key Features

Best practices for cardiovascular disease prevention, care and outcomes. 12.75 AMA PRA Category I Credits™, and ABIM MOC.

Topics Covered

Essentials of cardiovascular disease, structural heart disease, ischemia, aortic stenosis, tricuspid regurgitation, hypertrophic cardiomyopathy, heart failure, atrial fibrillation, syncope, statins, dietary impact, pharmacotherapy, hypertension, special populations, hormone therapy, rehab, peripheral artery disease, pacemakers, wearables and much more!

Learning Objectives

 

Upon completion of this activity, the participant will be able to:

1. Reduce cardiovascular risks through optimal management of dyslipidemia, hypertension, diabetes and obesity.
2. Address the issues associated with primary prevention therapy in specific populations including women and the elderly.
3. Describe innovations in diagnostic modalities and their clinical use to screen, diagnose and treat patients with cardiovascular disease.
4. Apply recent evidence on mitral regurgitation, cardiac murmurs and aortic stenosis into clinical decision making for patients with structural heart disease.
5. Employ evidence-based therapies and consensus guidelines for the diagnosis, evaluation and management across the entire spectrum of patients with heart failure and cardiomyopathy.
6. Utilize current evidence and guideline recommendations to detect and manage patients with cardiac arrhythmias.

 

Target Audience

Providers who care for patients at risk for CVD and those with acute and chronic cardiovascular conditions, including general cardiologists, internal medicine specialists, primary care providers, family physicians, residents, fellows, nurse practitioners, physician assistants, nurses, and pharmacists.

Reviews

There are no reviews yet.

Be the first to review “Cleveland Clinic Cardiovascular Update 2025”

Your email address will not be published. Required fields are marked *